Medtronic plc (MDT)
Medtronic plc is a global leader in medical technology, specializing in medical devices, therapies, and solutions for various chronic diseases. Founded in 1949 and headquartered in Ireland, the company develops products for areas such as cardiac and vascular care, diabetes management, neurological disorders, and surgical equipment, aiming to improve patient outcomes and healthcare efficiency worldwide.
Dividend History
Investors can expect a dividend payout of $0.71 per share, scheduled to be distributed in 10 days on October 17, 2025
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| October 17, 2025 | $0.71 | 2025-09-26 | 2025-09-26 |
| July 11, 2025 | $0.71 | 2025-06-27 | 2025-06-27 |
| April 11, 2025 | $0.70 | 2025-03-28 | 2025-03-28 |
| January 10, 2025 | $0.70 | 2024-12-27 | 2024-12-27 |
| October 11, 2024 | $0.70 | 2024-09-27 | 2024-09-27 |
Dividends Summary
- Medtronic plc has issued 87 dividend payments over the past 21 years
- The most recent dividend was paid 88 days ago, on July 11, 2025
- The highest dividend payed out to investors during this period was $0.71 per share
- The average dividend paid during this period was $0.37 per share.
Company News
The connected drug delivery devices market is projected to grow from USD 7.44 billion in 2024 to USD 61.08 billion by 2034, driven by increasing demand for smart therapeutics, improved medication adherence, and remote patient monitoring across chronic disease management.
Medtronic offers potential protection against inflation through its innovative medical devices, strong pricing power, consistent financial performance, and 48-year history of dividend increases. The company's unique products like PulseSelect and upcoming Hugo robotic surgery system position it well in the healthcare market.
The U.S. Commerce Department launched a national security review of medical imports to assess reliance on foreign suppliers for critical health products, examining medical devices, PPE, and consumables under Section 232 of the Trade Expansion Act.
Intuitive Surgical, the leading developer of robotic surgical systems, reported strong Q4 2024 results with 18% growth in da Vinci procedure volume. However, the company expects a slowdown in procedure volume growth to 13-16% in 2025.
Medtronic's (MDT) stock suffers as a result of geopolitical complications and supply issues despite an expanding portfolio and strong strategic executions.
